Cargando…

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D

OBJECTIVE: To help facilitate economic evaluations of oncology treatments, we mapped responses on cancer-specific instrument to generic preference-based measures. METHODS: Cancer patients (n = 367) completed one cancer-specific instrument, the FACT-G, and two preference-based measures, the EQ-5D and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teckle, Paulos, McTaggart-Cowan, Helen, Van der Hoek, Kim, Chia, Stephen, Melosky, Barb, Gelmon, Karen, Peacock, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220776/ https://www.ncbi.nlm.nih.gov/pubmed/24289488 http://dx.doi.org/10.1186/1477-7525-11-203

Ejemplares similares

The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities
por: Teckle, Paulos, et al.
Publicado: (2011)

The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study
por: McTaggart-Cowan, Helen, et al.
Publicado: (2022)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping
por: Gray, Laura A., et al.
Publicado: (2018)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population
por: Kim, Seon-Ha, et al.
Publicado: (2014)

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
por: Barton, Garry R, et al.
Publicado: (2009)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease
por: Monroy, Manuel, et al.
Publicado: (2018)

Qualitative Findings on the Impact of Disease in Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM
por: Watson, Crystal, et al.
Publicado: (2020)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
por: Hagiwara, Yasuhiro, et al.
Publicado: (2020)

A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Chen, Jing, et al.
Publicado: (2014)

Impact of a cancer diagnosis on the income of adult cancer survivors: a scoping review protocol
por: El Adam, Shiraz, et al.
Publicado: (2021)

Impact of cancer on income, wealth and economic outcomes of adult cancer survivors: a scoping review
por: Bentley, Colene, et al.
Publicado: (2022)

Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China
por: Yang, Qing, et al.
Publicado: (2023)

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30
por: McTaggart-Cowan, Helen, et al.
Publicado: (2019)

Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients
por: Diels, J., et al.
Publicado: (2014)

The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya
por: Patel, Anik R., et al.
Publicado: (2017)

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
por: Mulhern, Brendan, et al.
Publicado: (2014)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

Understanding cancer survivors’ reasons to medicate with cannabis: A qualitative study based on the theory of planned behavior
por: McTaggart‐Cowan, Helen, et al.
Publicado: (2020)

Comparison of two utility instruments, the EQ-5D and the 15D, in the critical care setting
por: Vainiola, Tarja, et al.
Publicado: (2010)

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis
por: Huppertz-Hauss, Gert, et al.
Publicado: (2016)

Long-term effects of cancer on earnings of childhood, adolescent and young adult cancer survivors – a population-based study from British Columbia, Canada
por: Teckle, Paulos, et al.
Publicado: (2018)

Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N
por: Huang, Deyu, et al.
Publicado: (2023)

A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain
por: Ye, Ziping, et al.
Publicado: (2019)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

Mapping the Insomnia Severity Index Instrument to EQ-5D Health State Utilities: A United Kingdom Perspective
por: Chalet, François-Xavier, et al.
Publicado: (2023)

Mapping onto Eq-5 D for patients in poor health
por: Versteegh, Matthijs M, et al.
Publicado: (2010)

Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
por: Kularatna, Sanjeewa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bkl29g7fk52ojgckkjqbfmto71